Adicet Bio, Inc. Profile Avatar - Palmy Investing

Adicet Bio, Inc.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies…

Biotechnology
US, Boston [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ACET's Analysis
CIK: 1720580 CUSIP: 007002108 LEI: - UEI: -
Secondary Listings
ACET has no secondary listings inside our databases.